Ibyerekeye-kanseri / kuvura / ibiyobyabwenge / byinshi-myeloma

Ibiyobyabwenge Byemewe kuri Myeloma myinshi nizindi Plasma Cell Neoplasms

Uru rupapuro rugaragaza imiti ya kanseri yemejwe n’ubuyobozi bushinzwe ibiryo n’ibiyobyabwenge (FDA) kuri myeloma nyinshi nizindi plasma neoplasme. Urutonde rurimo amazina rusange, amazina yikirango, hamwe nibiyobyabwenge bisanzwe, bigaragazwa ninyuguti nkuru. Amazina yibiyobyabwenge ahuza incamake yamakuru ya Kanseri ya NCI. Hashobora kuba hari imiti ikoreshwa muri myeloma myinshi hamwe nizindi plasma selile neoplasme zitanditswe hano.

Ibiyobyabwenge Byemewe kuri Myeloma myinshi nizindi Plasma Cell Neoplasms

Alkeran yo gutera inshinge (Melphalan Hydrochloride)

Ibinini bya Alkeran (Melphalan)

Aredia (Pamidronate Disodium)

BiCNU (Carmustine)

Bortezomib

Carfilzomib

Carmustine

Cyclophosphamide

Daratumumab

Darzalex (Daratumumab)

Doxil (Doxorubicin Hydrochloride Liposome)

Doxorubicin Hydrochloride Liposome

Elotuzumab

Empliciti (Elotuzumab)

Evomela (Melphalan Hydrochloride)

Farydak (Panobinostat)

Ixazomib Citrate

Kyprolis (Carfilzomib)

Lenalidomide

Melphalan

Melphalan Hydrochloride

Mozobil (Plerixafor)

Ninlaro (Citrate Ixazomib)

Pamidronate Disodium

Panobinostat

Plerixafor

Pomalidomide

Pomalyst (Pomalidomide)

Revlimid (Lenalidomide)

Selinexor

Thalidomide

Thalomide (Thalidomide)

Velcade (Bortezomib)

Xpovio (Selinexor)

Acide Zoledronic

Zometa (Acide Zoledronic)

Ibiyobyabwenge Byifashishwa muri Multi Myeloma nizindi Plasma Cell Neoplasms

PAD